YU43269B - Process for the manufacture od quinoline derivatives - Google Patents

Process for the manufacture od quinoline derivatives

Info

Publication number
YU43269B
YU43269B YU1232/82A YU123282A YU43269B YU 43269 B YU43269 B YU 43269B YU 1232/82 A YU1232/82 A YU 1232/82A YU 123282 A YU123282 A YU 123282A YU 43269 B YU43269 B YU 43269B
Authority
YU
Yugoslavia
Prior art keywords
manufacture
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
YU1232/82A
Other languages
English (en)
Other versions
YU123282A (en
Inventor
T P Blckburn
B Cox
A J Guildford
Count D J Le
R J Pearce
C W Thornber
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of YU123282A publication Critical patent/YU123282A/xx
Publication of YU43269B publication Critical patent/YU43269B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
YU1232/82A 1981-06-09 1982-06-08 Process for the manufacture od quinoline derivatives YU43269B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8117642 1981-06-09

Publications (2)

Publication Number Publication Date
YU123282A YU123282A (en) 1985-04-30
YU43269B true YU43269B (en) 1989-06-30

Family

ID=10522379

Family Applications (2)

Application Number Title Priority Date Filing Date
YU1232/82A YU43269B (en) 1981-06-09 1982-06-08 Process for the manufacture od quinoline derivatives
YU1882/84A YU42905B (en) 1981-06-09 1984-11-08 Process for the manufacture of quinoline derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU1882/84A YU42905B (en) 1981-06-09 1984-11-08 Process for the manufacture of quinoline derivatives

Country Status (25)

Country Link
US (1) US4435405A (cs)
EP (1) EP0066993B1 (cs)
JP (1) JPS58965A (cs)
AR (1) AR230437A1 (cs)
AT (1) ATE11534T1 (cs)
AU (1) AU556719B2 (cs)
CA (1) CA1189077A (cs)
CS (1) CS238624B2 (cs)
DE (1) DE3262122D1 (cs)
DK (1) DK152428C (cs)
ES (3) ES8401034A1 (cs)
FI (1) FI77451C (cs)
GR (1) GR76452B (cs)
HU (1) HU186523B (cs)
IE (1) IE53064B1 (cs)
IL (1) IL65852A (cs)
IN (1) IN158970B (cs)
NO (1) NO161066C (cs)
NZ (1) NZ200878A (cs)
PH (1) PH18503A (cs)
PL (1) PL135871B1 (cs)
PT (1) PT75024B (cs)
SU (1) SU1192618A3 (cs)
YU (2) YU43269B (cs)
ZA (1) ZA823586B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3371511D1 (en) * 1982-04-07 1987-06-19 Ici Plc Quinoline derivatives
DE3377796D1 (en) * 1982-05-04 1988-09-29 Ici Plc Quinoline derivatives
US4585866A (en) * 1982-06-09 1986-04-29 Merrell Dow Pharmaceuticals Inc. Treatment of migraine with substituted tropyl benzoate derivatives
GB8308601D0 (en) * 1983-03-29 1983-05-05 Ici Plc Heterocyclic compounds
JPS60166406A (ja) * 1984-02-09 1985-08-29 株式会社イナックス 乾式プレス装置の坏土充填方法
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
JP2733511B2 (ja) * 1988-10-22 1998-03-30 日本臓器製薬株式会社 新規アミノアルカン誘導体
JPH03147803A (ja) * 1989-11-06 1991-06-24 Tiger Mach Seisakusho:Kk 表面多色変化模様のあるコンクリートブロックの製造方法
US6566361B2 (en) 1999-06-30 2003-05-20 Laboratories, Upsa Azapirone pain treatment
FR2795645B1 (fr) * 1999-06-30 2001-09-21 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
EP1216988A4 (en) 1999-09-28 2005-04-20 Nihon Nohyaku Co Ltd THIOALKYLAMINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
FR2810664B1 (fr) * 2000-06-27 2004-12-24 Adir Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US9198903B2 (en) 2007-02-28 2015-12-01 Thromboserin Limited Method of treating or preventing thrombosis in a patient with 5-HT2A receptor antagonist thromboserin
JP2011507835A (ja) 2007-12-21 2011-03-10 アンドレイ・アレクサンドロビッチ・イワシェンコ α−アドレナリン受容体、ドーパミン、ヒスタミン、イミダゾリン及びセロトニン受容体のリガンド並びにその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1049379B (de) 1959-01-29 Farbenfabriken Bayer Aktiengesellschaft, Leverkusen-Bayerwerk Verfahren zur Herstellung von 4 - (tert.-Aminoalkylmercapto)chinolinverbindungen
DE430960C (de) 1924-07-11 1926-06-23 J G Farbenindustrie Akt Ges Verfahren zur Darstellung von basischen AEthern von Chinolinderivaten
US1572768A (en) 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
US1860286A (en) 1929-05-16 1932-05-24 Soc Of Chemical Ind Basic ethers of aryl-quinolines
GB1511390A (en) * 1975-12-04 1978-05-17 Pfizer Ltd Imidazolylalkyl sulphide antifungal agents
US4343805A (en) 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds

Also Published As

Publication number Publication date
NO161066C (no) 1989-06-28
AR230437A1 (es) 1984-04-30
EP0066993A1 (en) 1982-12-15
ES512960A0 (es) 1983-12-01
ES8402576A1 (es) 1984-02-01
SU1192618A3 (ru) 1985-11-15
PL135871B1 (en) 1985-12-31
YU123282A (en) 1985-04-30
PT75024A (en) 1982-07-01
IE53064B1 (en) 1988-05-25
CS425382A2 (en) 1984-02-13
IE821243L (en) 1982-12-09
YU42905B (en) 1988-12-31
DE3262122D1 (en) 1985-03-14
JPS58965A (ja) 1983-01-06
NO821904L (no) 1982-12-10
ATE11534T1 (de) 1985-02-15
ZA823586B (en) 1983-03-30
ES8401034A1 (es) 1983-12-01
IN158970B (cs) 1987-02-28
FI77451B (fi) 1988-11-30
PL236836A1 (en) 1983-09-12
ES525298A0 (es) 1985-01-16
EP0066993B1 (en) 1985-01-30
NO161066B (no) 1989-03-20
DK152428B (da) 1988-02-29
PH18503A (en) 1985-08-02
AU8386382A (en) 1982-12-16
YU188284A (en) 1985-10-31
DK152428C (da) 1988-08-15
PT75024B (en) 1984-05-08
ES8502688A1 (es) 1985-01-16
FI821965A0 (fi) 1982-06-02
HU186523B (en) 1985-08-28
GR76452B (cs) 1984-08-10
ES519006A0 (es) 1984-02-01
IL65852A0 (en) 1982-08-31
CS238624B2 (en) 1985-12-16
AU556719B2 (en) 1986-11-13
JPH0424349B2 (cs) 1992-04-24
DK257782A (da) 1982-12-10
CA1189077A (en) 1985-06-18
IL65852A (en) 1986-04-29
US4435405A (en) 1984-03-06
NZ200878A (en) 1985-02-28
FI77451C (fi) 1989-03-10

Similar Documents

Publication Publication Date Title
YU25682A (en) Process for obtaining anittumoral quinazoline derivatives
YU43269B (en) Process for the manufacture od quinoline derivatives
DE3278474D1 (en) Process for the preparation of di-galactose derivatives
AR240739A1 (es) Procedimiento para preparar derivados de quinolinona
CU21425A3 (en) Procedure for the dimethylathers production
HU185109B (en) Process for preparing imidazo-quinazoline derivatives
ZA825858B (en) Process for the production of 2- -d-ribofuranosylthiazole-4-carboxamide
EP0155710A3 (en) Process for the preparation of derivatives of polyethoxypropanesulfonates
GB2108491B (en) Process for preparing 3-exo-methylenecepham derivatives
PT74254B (en) Process for the preparation of pyridinyl-substituted-benzimidazole derivatives
YU105982A (en) Process for foam-flotation
YU217582A (en) Process for obtaining azolyl-pentene derivatives
YU50782A (en) Process for the manufacture of substituted trifluoromethylphenyl-tetrahydropyridines
DE3462254D1 (en) Process for the preparation of quinolines
YU141582A (en) Process for obtining new benzoyl-phenyl-piperidine derivatives
DE3263410D1 (en) Process for the continuous production of quinoline salts
GB2111516B (en) Processes for the production of polyesterpolycarbonates
DE3260739D1 (en) Process for making 2-carbalkoxy-5-carboxynitrobenzenes
DE3260445D1 (en) Process for the preparation of 17-alpha-ethynyl-17-beta-trifluoroacetoxy-gon-4-en-3-one derivatives
GB2108492B (en) Process for preparing oxazolineazetidinone derivatives
YU271082A (en) Improved process for the production of encainides
DE3262838D1 (en) Process for the preparation of pyridines
DE3272497D1 (en) Process for the preparation of 2-aminopyridine derivatives
GB2108110B (en) Process for preparing 2-oxycephalosporin derivatives
YU26682A (en) Process for the manufacture of pyrbuterol